Brian Claggett
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Blood Pressure and Hypertension Studies
-
- Diabetes Treatment and Management
- Hormonal Regulation and Hypertension
Papers in
-
- Heart Failure Treatment and Management 139
- Cardiovascular Function and Risk Factors 80
- Blood Pressure and Hypertension Studies 21
-
- Diabetes Treatment and Management 47
- Hormonal Regulation and Hypertension 21
- Co-authors
- Scott D. Solomon (251 shared papers)John J.V. McMurray (251 shared papers)Akshay S. Desai (159 shared papers)Amil M. Shah (113 shared papers)Michael R. Zile (101 shared papers)Marc A. Pfeffer (130 shared papers)Milton Packer (75 shared papers)Jean L. Rouleau (93 shared papers)
- Journals
- European Journal of Heart Failure (77 papers)JACC Heart Failure (56 papers)Journal of the American College of Cardiology (55 papers)JAMA Cardiology (36 papers)Circulation (34 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Brian Claggett
522 papers receiving 20.0k citations
Brian Claggett's Hit Papers
Peers
Comparison fields: 5 of 170
- Cardiology and Cardiovascular Medicine 10.1k
- Endocrinology, Diabetes and Metabolism 3.3k
- Nephrology 544
- Statistics and Probability 634
- Pulmonary and Respiratory Medicine 2.1k
Countries citing papers authored by Brian Claggett
This map shows the geographic impact of Brian Claggett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Claggett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Claggett more than expected).
Fields of papers citing papers by Brian Claggett
This network shows the impact of papers produced by Brian Claggett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Claggett. The network helps show where Brian Claggett may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Claggett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 564 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials Hit paper breakdown → | 2022 | 530 |
| 2 | Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis Hit paper breakdown → | 2018 | 518 |
| 3 | Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis Hit paper breakdown → | 2014 | 444 |
| 4 | Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials Hit paper breakdown → | 2020 | 372 |
| 5 | Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction Hit paper breakdown → | 2015 | 340 |
| 6 | Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone Hit paper breakdown → | 2015 | 331 |
| 7 | Sex Differences in Blood Pressure Trajectories Over the Life Course Hit paper breakdown → | 2020 | 315 |
| 8 | Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients Hit paper breakdown → | 2015 | 302 |
| 9 | Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure Hit paper breakdown → | 2018 | 293 |
| 10 | Heart Failure with Mid-Range Ejection Fraction in CHARM: Characteristics, Outcomes and Effect of Candesartan Across the Entire Ejection Fraction Spectrum Hit paper breakdown → | 2018 | 281 |
| 11 | 2016 | 248 | |
| 12 | 2017 | 241 | |
| 13 | 2016 | 238 | |
| 14 | 2020 | 233 | |
| 15 | Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction Hit paper breakdown → | 2019 | 231 |
| 16 | 2016 | 218 | |
| 17 | 2014 | 197 | |
| 18 | 2019 | 195 | |
| 19 | Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the Hit paper breakdown → | 2021 | 191 |
| 20 | 2014 | 185 |
About Brian Claggett
Brian Claggett is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology, Surgery and Pulmonary and Respiratory Medicine, having authored 564 papers that have together received 20.3k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (139 papers), Cardiovascular Function and Risk Factors (80 papers), Diabetes Treatment and Management (47 papers), Influenza Virus Research Studies (30 papers), Blood Pressure and Hypertension Studies (21 papers), Hormonal Regulation and Hypertension (21 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers) and Statistical Methods in Clinical Trials (16 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (10.1k citations), Endocrinology, Diabetes and Metabolism (3.3k citations), Nephrology (544 citations), Statistics and Probability (634 citations) and Pulmonary and Respiratory Medicine (2.1k citations). Brian Claggett has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Scott D. Solomon, John J.V. McMurray, Akshay S. Desai, Amil M. Shah, Michael R. Zile, Marc A. Pfeffer, Milton Packer, Jean L. Rouleau, Martin Lefkowitz and Karl Swedberg. Their work appears in journals such as European Journal of Heart Failure, JACC Heart Failure, Journal of the American College of Cardiology, JAMA Cardiology and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.